Dexamethasone, High-Dose Cytarabine, and Cisplatin in Combination with Rituximab as Salvage Treatment for Patients with Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma

Author： Mey Ulrich   Orlopp Katjana   Flieger Dimitri   Strehl John   Ho Anthony   Hensel Manfred   Bopp Cordula   Gorschlüter Marcus   Wilhelm Martin   Birkmann Josef   Kaiser Ulrich   Neubauer Andreas   Florschütz Axel   Rabe Christian   Hahn Corinna   Glasmacher Axel   Schmidt-Wolf Ingo  

Publisher： Informa Healthcare

ISSN： 0735-7907

Source： Cancer Investigation, Vol.24, Iss.6, 2006-09, pp. : 593-600

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gemcitabine, oxaliplatin and dexamethasone as salvage treatment for elderly patients with refractory and relapsed peripheral T-cell lymphoma

By Yao Yi-yun   Tang Yong   Zhu Qi   Zhuang Yan   Cheng Yi-min   Wang Lei   Zou Li-fang  

Leukemia and Lymphoma, Vol. 54, Iss. 6, 2013-06 ,pp. : 1194-1200

Informa Healthcare

Access to resources Recommend Favorite

Preliminary outcome of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin’s lymphoma: single institution experience

By Wang Bufei   Huang Huiqiang   Bu Qing   Xia Zhongjun   Lin Xubin   Wang Fenghua   Li Yuhong   Peng Yulong   Pan Zhanhe   Wang Shusen   Lin Tongyu   Jiang Wenqi   Guan Zhongzhen  

The Chinese-German Journal of Clinical Oncology, Vol. 5, Iss. 6, 2006-12 ,pp. : 402-406

Springer Publishing Company

Access to resources Recommend Favorite

Comparison of ICE (Ifosfamide-Carboplatin-Etoposide) Versus DHAP (Cytosine Arabinoside-Cisplatin-Dexamethasone) as Salvage Chemotherapy in Patients with Relapsed or Refractory Lymphoma

By Abalı Huseyin   Urun Yuksel   Oksuzoğlu Berna   Budakoğlu Burcin   Yıldırım Nuriye   Guler Tunc   Ozet Gulsum   Zengin Nurullah  

Cancer Investigation, Vol. 26, Iss. 4, 2008-05 ,pp. : 401-406

Informa Healthcare

Access to resources Recommend Favorite

High-dose idarubicin in combination with Ara-C in patients with relapsed or refractory acute lymphoblastic leukemia: a pharmacokinetic and clinical study

By Tedeschi Alessandra   Montillo Marco   Strocchi Elena   Cafro Anna   Tresoldi Elisabetta   Intropido Liliana   Nichelatti Michele   Marbello Laura   Baratè Claudia   Camaggi Carlo   Morra Enrica  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 6, 2007-06 ,pp. : 771-779

Springer Publishing Company

Access to resources Recommend Favorite

Parental longevity and prognosis in elderly patients with aggressive non-hodgkin's lymphoma

By Ösby Eva   Askling Johan   Landgren Ola   Dickman Paul   Ekbom Anders   Björkholm Magnus  

Acta Oncologica, Vol. 43, Iss. 3, 2004-04 ,pp. : 297-301

Informa Healthcare

Access to resources Recommend Favorite